The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary efficacy and safety of TQB2102 in patients with HER2 low-expressing recurrent/metastatic breast cancer: Results from a phase 1b study.
 
Shusen Wang
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo
Speakers' Bureau - AstraZeneca; Lilly; Novartis; Pfizer; Roche
Research Funding - AstraZeneca; Pfizer
 
Qingyuan Zhang
No Relationships to Disclose
 
Jin Yang
No Relationships to Disclose
 
Tao Sun
No Relationships to Disclose
 
Shaoyan Lin
No Relationships to Disclose
 
Yehui Shi
No Relationships to Disclose
 
Jingfen Wang
No Relationships to Disclose
 
FEI Luo
No Relationships to Disclose
 
Xiujuan Qu
No Relationships to Disclose
 
Huihui Li
No Relationships to Disclose
 
Weimin Xie
No Relationships to Disclose
 
Hongxue Wang
No Relationships to Disclose
 
Chunjiao Wu
No Relationships to Disclose
 
Changlu Hu
No Relationships to Disclose
 
Hongwei Yang
No Relationships to Disclose
 
Hong Wang
No Relationships to Disclose
 
Fan Feng
Employment - Chia Tai Tianqing Pharmaceutical Group
Honoraria - Chia Tai Tianqing Pharmaceutical Group
 
Yang Yu
Employment - Chia Tai Tianqing Pharmaceutical Group
Honoraria - Chia Tai Tianqing Pharmaceutical Group
 
Jie Chen
Employment - Chia Tai Tianqing Pharmaceutical Group
Honoraria - Chia Tai Tianqing Pharmaceutical Group